Clinical Study
Angiogenesis-Related Cytokines, RANKL, and Osteoprotegerin in Multiple Myeloma Patients in relation to Clinical Features and Response to Treatment
Table 5
Mean ± SD values of the measured parameters in MM patients before and after treatment.
| | | Mean ± SD | (Wilcoxon test) |
| OPG (pmol/L) | Before treatment | | < 0.03 | | After treatment | | | RANKL (pmol/L) | Before treatment | | < 0.005 | | After treatment | | | RANKL/OPG | Before treatment | | < 0.01 | | After treatment | | | HGF (pg/mL) | Before treatment | | < 0.001 | | After treatment | | | LDH (IU/L) | Before treatment | | < 0.002 | | After treatment | | | VEGF (pg/mL) | Before treatment | | < 0.001 | | After treatment | | | IL-6 (pg/mL) | Before treatment | | < 0.003 | | After treatment | | |
|
|